Abbvie (ABBV) Holder Lipe & Dalton Has Lifted Position; Jlb & Associates Boosted Its Marsh & Mc Lennan (MMC) Holding

Marsh & McLennan Companies, Inc. (NYSE:MMC) Logo

Lipe & Dalton increased its stake in Abbvie Inc (ABBV) by 163.02% based on its latest 2018Q3 regulatory filing with the SEC. Lipe & Dalton bought 8,200 shares as the company’s stock declined 6.62% with the market. The institutional investor held 13,230 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $1.25M, up from 5,030 at the end of the previous reported quarter. Lipe & Dalton who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $132.34 billion market cap company. The stock decreased 0.25% or $0.22 during the last trading session, reaching $87.98. About 1.47M shares traded. AbbVie Inc. (NYSE:ABBV) has declined 7.04% since January 11, 2018 and is downtrending. It has underperformed by 7.04% the S&P500. Some Historical ABBV News: 12/03/2018 – ADVAXIS: STUDY OF AXALIMOGENE FILOLISBAC W/ IMFINZI ON HOLD; 13/03/2018 – ABBVIE INC – RESULTS WERE CONSISTENT WITH FIRST PHASE 3 STUDY; 13/03/2018 – Merck Gets FDA Priority Review for Keytruda sBLA in Advanced Cervical Cancer; 23/04/2018 – EMA VALIDATES TYPE II VARIATION FOR MERCK & CO’S KEYTRUDA; 05/04/2018 – BIOGEN INC – UNDER TERMS OF AGREEMENT, ABBVIE WILL GRANT PATENT LICENSES FOR USE AND SALE OF IMRALDI IN EUROPE; 26/04/2018 – AbbVie’s beat fueled by demand for Humira, Hep C drugs; 22/03/2018 – BerGenBio to Present Overview of Phase Il Clinical Trial Portfolio Combining Bemcentinib With KEYTRUDA at 3rd Annual Immuno-Oncology Summit Europe; 11/04/2018 – MYLAN, BIOCON SEEK TO ACCELERATE INTRODUCTION OF ADALIMUMAB BIOSIMILAR IN EU; 26/04/2018 – ABBVIE 1Q ADJ. EPS $1.87, EST. $1.79; BOOSTS FORECAST; 24/04/2018 – MERCK PHASE 1 KEYTRUDA STUDY SUSPENDED: CLINICALTRIALS.GOV

Jlb & Associates Inc increased its stake in Marsh & Mc Lennan (MMC) by 6.47% based on its latest 2018Q3 regulatory filing with the SEC. Jlb & Associates Inc bought 5,169 shares as the company’s stock declined 1.83% with the market. The institutional investor held 85,085 shares of the finance company at the end of 2018Q3, valued at $7.04 million, up from 79,916 at the end of the previous reported quarter. Jlb & Associates Inc who had been investing in Marsh & Mc Lennan for a number of months, seems to be bullish on the $40.55B market cap company. The stock decreased 1.18% or $0.96 during the last trading session, reaching $80.5. About 401,295 shares traded. Marsh & McLennan Companies, Inc. (NYSE:MMC) has risen 1.00% since January 11, 2018 and is uptrending. It has outperformed by 1.00% the S&P500. Some Historical MMC News: 19/04/2018 – MMC CORPORATION BHD MMCB.KL – UNIT GETS CONTRACT FOR WORKS WORTH 138.0 MLN RGT FROM FROM MINISTRY OF DEFENCE MALAYSIA; 24/04/2018 – Interior-Parks: Public Comment Sought on Eastern Great Marsh Project in National Lakeshore; 08/05/2018 – Mercer’s Tracy Watts Named ‘Top 25 Consultant’ by Consulting® Magazine; 05/04/2018 – Fitch Upgrades Marsh & McLennan to ‘A’; Outlook Stable; 07/05/2018 – Marsh & McLennan Companies Names Erick R. Gustafson Chief Public Affairs Officer; 13/03/2018 – Florida Governor: Governor Scott Appoints James “Lee” Marsh to the Second Judicial Circuit Court; 26/03/2018 – AIG hires general insurance marketing chief from MMC; 14/05/2018 – Marsh & McLennan Companies to Webcast 2018 Annual Meeting of Stockholders on May 17; 17/05/2018 – MARSH & MCLENNAN: QTRLY DIV INCREASED FROM $0.375 TO $0.415; 03/05/2018 – Howard Marsh Metropark, Designed by SmithGroupJJR, Opens in Toledo Area

Among 17 analysts covering Marsh & McLennan (NYSE:MMC), 7 have Buy rating, 1 Sell and 9 Hold. Therefore 41% are positive. Marsh & McLennan had 45 analyst reports since September 8, 2015 according to SRatingsIntel. Citigroup maintained the stock with “Buy” rating in Friday, February 9 report. The rating was upgraded by Bank of America to “Buy” on Friday, January 27. Wells Fargo maintained the shares of MMC in report on Friday, April 28 with “Buy” rating. RBC Capital Markets maintained the shares of MMC in report on Friday, December 8 with “Buy” rating. The firm has “Neutral” rating given on Wednesday, December 6 by UBS. As per Thursday, July 27, the company rating was maintained by RBC Capital Markets. RBC Capital Markets maintained the shares of MMC in report on Monday, August 28 with “Buy” rating. The stock of Marsh & McLennan Companies, Inc. (NYSE:MMC) has “Buy” rating given on Thursday, December 21 by Keefe Bruyette & Woods. The company was maintained on Tuesday, February 20 by Barclays Capital. Keefe Bruyette & Woods maintained Marsh & McLennan Companies, Inc. (NYSE:MMC) on Friday, October 27 with “Buy” rating.

Investors sentiment increased to 1.16 in Q3 2018. Its up 0.16, from 1 in 2018Q2. It increased, as 21 investors sold MMC shares while 213 reduced holdings. 71 funds opened positions while 200 raised stakes. 416.43 million shares or 0.13% less from 416.99 million shares in 2018Q2 were reported. Davis Selected Advisers, a Arizona-based fund reported 311,328 shares. Jcic Asset has invested 0% in Marsh & McLennan Companies, Inc. (NYSE:MMC). Rhumbline Advisers has 0.15% invested in Marsh & McLennan Companies, Inc. (NYSE:MMC) for 963,809 shares. Connecticut-based Paloma Prns Mgmt has invested 0.01% in Marsh & McLennan Companies, Inc. (NYSE:MMC). Willingdon Wealth Mgmt invested 0.02% in Marsh & McLennan Companies, Inc. (NYSE:MMC). Lafayette Investments Inc holds 1.48% or 51,942 shares. Cornerstone Advsrs Incorporated accumulated 0.08% or 14,000 shares. Cutler Invest Counsel Ltd invested in 85,038 shares or 1.32% of the stock. Lazard Asset Mgmt Llc holds 0.01% or 43,398 shares. Qci Asset Management New York has 0% invested in Marsh & McLennan Companies, Inc. (NYSE:MMC). Johnson Inv Counsel Incorporated reported 511,554 shares stake. Mercer Capital Advisers Inc has invested 0.31% of its portfolio in Marsh & McLennan Companies, Inc. (NYSE:MMC). Bbva Compass Bancorp invested in 64,100 shares. Dekabank Deutsche Girozentrale reported 0.45% of its portfolio in Marsh & McLennan Companies, Inc. (NYSE:MMC). New Vernon Investment Ltd holds 2.18% or 22,276 shares.

Since August 29, 2018, it had 0 insider buys, and 1 insider sale for $6.83 million activity.

More notable recent Marsh & McLennan Companies, Inc. (NYSE:MMC) news were published by: Businesswire.com which released: “Mark Chronister and Larry Chim Appointed to Key Leadership Roles in Mercer’s Dallas Office – Business Wire” on September 26, 2018, also Businesswire.com with their article: “Marsh and Evident to Launch Blockchain Solution for Sharing Economy – Business Wire” published on October 02, 2018, Streetinsider.com published: “Marsh & McLennan (MMC) Announces Acquisition of Klein Agency Inc. in St. Paul, Minnesota – StreetInsider.com” on July 03, 2018. More interesting news about Marsh & McLennan Companies, Inc. (NYSE:MMC) were released by: Seekingalpha.com and their article: “Marsh & McLennan’s Mercer unit in pacts for two acquisitions – Seeking Alpha” published on August 14, 2018 as well as Businesswire.com‘s news article titled: “Marsh & McLennan Companies Holds 2018 Stockholders’ Meeting – Business Wire” with publication date: May 17, 2018.

Jlb & Associates Inc, which manages about $350.10 million and $467.00M US Long portfolio, decreased its stake in Graco (NYSE:GGG) by 10,158 shares to 299,211 shares, valued at $13.87M in 2018Q3, according to the filing. It also reduced its holding in Nike (NYSE:NKE) by 6,699 shares in the quarter, leaving it with 134,644 shares, and cut its stake in Microsoft (NASDAQ:MSFT).

Since August 17, 2018, it had 0 insider purchases, and 6 sales for $26.66 million activity. 60,000 shares were sold by CHASE WILLIAM J, worth $5.40 million. GONZALEZ RICHARD A sold $1.50M worth of stock. Shares for $3.82 million were sold by Gosebruch Henry O on Thursday, November 29. Shares for $4.88 million were sold by SEVERINO MICHAEL on Friday, August 17.

Among 26 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 3 Sell and 13 Hold. Therefore 38% are positive. Abbvie Inc had 105 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Underperform” rating by BMO Capital Markets given on Friday, March 23. UBS maintained it with “Buy” rating and $78 target in Friday, October 23 report. The rating was maintained by Jefferies with “Buy” on Friday, March 23. The stock of AbbVie Inc. (NYSE:ABBV) has “Hold” rating given on Wednesday, April 19 by BMO Capital Markets. Jefferies maintained AbbVie Inc. (NYSE:ABBV) rating on Friday, January 26. Jefferies has “Buy” rating and $150.0 target. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by SunTrust on Sunday, October 29. BMO Capital Markets maintained the shares of ABBV in report on Wednesday, October 11 with “Hold” rating. Deutsche Bank maintained the stock with “Hold” rating in Monday, July 17 report. The firm earned “Buy” rating on Monday, December 7 by Jefferies. As per Monday, June 6, the company rating was downgraded by Cowen & Co.

Investors sentiment decreased to 0.82 in 2018 Q3. Its down 0.12, from 0.94 in 2018Q2. It fall, as 60 investors sold ABBV shares while 637 reduced holdings. 107 funds opened positions while 466 raised stakes. 994.12 million shares or 0.91% less from 1.00 billion shares in 2018Q2 were reported. Coldstream Capital Mngmt stated it has 0.34% of its portfolio in AbbVie Inc. (NYSE:ABBV). The Massachusetts-based Baldwin Brothers Ma has invested 0.06% in AbbVie Inc. (NYSE:ABBV). Stewart & Patten Co Ltd Co reported 15,204 shares stake. Arcadia Inv Corp Mi has 70,171 shares. Murphy Capital Management Inc has 8,066 shares for 0.11% of their portfolio. Polaris Greystone Group Limited Co owns 5,966 shares. Leavell Investment Mngmt has invested 0.71% in AbbVie Inc. (NYSE:ABBV). Catalyst Cap Advsrs Limited Liability Corporation owns 2,758 shares for 0.01% of their portfolio. Trustco Natl Bank N Y owns 2.95% invested in AbbVie Inc. (NYSE:ABBV) for 28,753 shares. Sather Inc holds 0.06% in AbbVie Inc. (NYSE:ABBV) or 3,100 shares. Middleton And Ma owns 142,899 shares or 2.11% of their US portfolio. Asset Management Of Georgia Ga Adv accumulated 0.71% or 10,731 shares. Moreover, Meiji Yasuda Asset Mgmt has 0.63% invested in AbbVie Inc. (NYSE:ABBV) for 81,757 shares. Cls Limited Liability Corporation stated it has 21,467 shares or 0.06% of all its holdings. Bruce accumulated 4.98% or 271,915 shares.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “AbbVie teams up with Voluntis in companion digital therapeutics – Seeking Alpha” on December 19, 2018, also Seekingalpha.com with their article: “Bristol-Myers Squibb may be takeover target after Celgene bid – Credit Suisse – Seeking Alpha” published on January 08, 2019, Streetinsider.com published: “AbbVie (ABBV), Tizona Therapeutics Report Strategic Collaboration to Develop First-in-Class Immunotherapy for Cancer Targeting CD39 – StreetInsider.com” on January 03, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “AbbVie revamps senior management – Seeking Alpha” published on December 17, 2018 as well as Seekingalpha.com‘s news article titled: “AbbVie boosts stock buybacks by $5B – Seeking Alpha” with publication date: December 13, 2018.

Marsh & McLennan Companies, Inc. (NYSE:MMC) Institutional Positions Chart